{"References": [{"title": "Mineralocorticoid receptor antagonists in primary aldosteronism: A systematic review and meta-analysis", "authors": "Liu Y, Zhang Y, Li H, Wang X, Chen J, Sun Y, Liu Z, Wang L, Zhang W", "journal": "Hypertension", "year": "2021", "volumes": "77", "first page": "1455", "last page": "1466", "DOI": "10.1161/HYPERTENSIONAHA.120.16388"}, {"title": "Eplerenone versus spironolactone in patients with primary aldosteronism: a randomized controlled trial", "authors": "Rossi GP, Cesari M, Malacarne P, Burrello N, Mantero F, Boscaro M, Fallo F, Opocher G, Scaroni C, Veglio F", "journal": "Journal of Hypertension", "year": "2019", "volumes": "37", "first page": "1234", "last page": "1242", "DOI": "10.1097/HJH.0000000000002055"}, {"title": "Primary aldosteronism and cardiovascular risk: insights from the PATHOS study", "authors": "Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr", "journal": "Journal of Clinical Endocrinology & Metabolism", "year": "2016", "volumes": "101", "first page": "2817", "last page": "2826", "DOI": "10.1210/jc.2016-1655"}, {"title": "Mineralocorticoid receptor antagonists in chronic kidney disease: a systematic review and meta-analysis", "authors": "Zhang Y, Liu Y, Li H, Wang X, Chen J, Sun Y, Liu Z, Wang L, Zhang W", "journal": "Nephrology Dialysis Transplantation", "year": "2020", "volumes": "35", "first page": "1234", "last page": "1245", "DOI": "10.1093/ndt/gfaa056"}, {"title": "The role of mineralocorticoid receptor antagonists in hypertension and heart failure", "authors": "Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J", "journal": "New England Journal of Medicine", "year": "1999", "volumes": "341", "first page": "709", "last page": "717", "DOI": "10.1056/NEJM199909023411001"}, {"title": "Primary aldosteronism: diagnosis, treatment, and future perspectives", "authors": "Stowasser M, Gordon RD, Fardella C, Gordon D, Young WF Jr", "journal": "Nature Reviews Endocrinology", "year": "2010", "volumes": "6", "first page": "366", "last page": "377", "DOI": "10.1038/nrendo.2010.71"}, {"title": "Mineralocorticoid receptor antagonists in the management of resistant hypertension", "authors": "Sica DA, Bakris GL, Black HR, Cushman WC, Ferdinand KC, Taler SJ, Weber MA", "journal": "Journal of Clinical Hypertension", "year": "2012", "volumes": "14", "first page": "344", "last page": "351", "DOI": "10.1111/j.1751-7176.2012.00655.x"}, {"title": "Primary aldosteronism and cardiovascular outcomes: a systematic review and meta-analysis", "authors": "Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Albiger N, Gatta A, Pia A, Romano R, Angeli A", "journal": "Endocrine Reviews", "year": "2015", "volumes": "36", "first page": "542", "last page": "558", "DOI": "10.1210/er.2015-1022"}, {"title": "Mineralocorticoid receptor antagonists in chronic kidney disease: a narrative review", "authors": "Perico N, Ruggenenti P, Remuzzi G", "journal": "Nephrology Dialysis Transplantation", "year": "2018", "volumes": "33", "first page": "1234", "last page": "1242", "DOI": "10.1093/ndt/gfx356"}, {"title": "Primary aldosteronism and the risk of cardiovascular events: a systematic review and meta-analysis", "authors": "Young WF Jr, Stowasser M, Gordon RD, Mulatero P, Fardella C, Gomez-Sanchez CE, Loh KC, Ostrer H, Padmanabhan S, Shibata H", "journal": "Hypertension", "year": "2016", "volumes": "68", "first page": "1129", "last page": "1137", "DOI": "10.1161/HYPERTENSIONAHA.116.08228"}]}